Smoking Cessation Using Motivational Therapy and Varenicline

• Status: Completed
• Trial end date: 2013-06-20
• Target enrollment: 0
• Participant gender: All

Summary

People that are infected with HIV appear to be especially susceptible to the adverse effects of cigarette smoking. The purpose of this study is to determine if quitting smoking by using a specialized smoking cessation treatment can prevent one from developing accelerated lung damage, particularly emphysema.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Philip Diaz
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Nicotine; Varenicline

Criteria

Inclusion Criteria:

1. 18 years of age and older;

2. diagnosis of HIV;

3. self-reported smoking on a daily basis;

4. provide informed written consent

Exclusion Criteria:

1. persons with active psychosis or impaired mental status as judged by the clinic staff and confirmed with a Mini-Mental Status Exam)

2. unable to understand spoken English

3. age less than 18 years.

4. pregnant women